You are here
Arete Therapeutics, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Amino acid derived urea based chemicals as sEH inhibitor
Amount: $100,000.00DESCRIPTION (provided by applicant): Recent findings indicate that increasing levels of epoxides of arachidonic acid (EETs) appear to be new and excellent means to treat both hypertension and vascula ...
STTRPhase I2005Department of Health and Human Services National Institutes of Health -
Novel epoxide hydrolase inhibitor for stroke prevention
Amount: $100,000.00DESCRIPTION (provided by applicant): A major cause of morbidity and mortality is the progression of organ damage associated with cardiovascular diseases. For instance, the incidence of stroke and cost ...
STTRPhase I2005Department of Health and Human Services National Institutes of Health -
Amino acid derived urea based chemicals as sEH inhibitor
Amount: $100,000.00DESCRIPTION (provided by applicant): Recent findings indicate that increasing levels of epoxides of arachidonic acid (EETs) appear to be new and excellent means to treat both hypertension and vascula ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Novel epoxide hydrolase inhibitor for stroke prevention
Amount: $100,000.00DESCRIPTION (provided by applicant): A major cause of morbidity and mortality is the progression of organ damage associated with cardiovascular diseases. For instance, the incidence of stroke and cost ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health